Bank of England warns of risk of AI market correction; gold hits new $4,000 an ounce record – business live | Business

Check out our latest products

Added to wishlistRemoved from wishlist 0
Add to compare
[Upgraded] USB Computer /Laptop Speaker with Stereo Sound & Enhanced Bass, Portable Mini Sound Bar for Windows PCs, Desktop Computer and Laptops
Added to wishlistRemoved from wishlist 0
Add to compare
16
Added to wishlistRemoved from wishlist 0
Add to compare
14 inch Laptop Computer, for Student, Windows 11, 2.6GHz Inter CPU, 8GB RAM, 256GB SSD, Thin, Lightweight, 6h Long Battery Life for Office & Study (N7P, Sliver)
Added to wishlistRemoved from wishlist 0
Add to compare
179
Added to wishlistRemoved from wishlist 0
Add to compare
14 Inch Laptop-Computer, Intel Celeron N3350 (Up to 2.4GHz), 6GB LPDDR4 RAM 320GB Storage, WI-FI 5, BT5.0, HD Camera, 34Wh Battery, Windows 10 Laptop for Home & Study, Lightweight
Added to wishlistRemoved from wishlist 0
Add to compare
Original price was: €240.Current price is: €200.
17%
Added to wishlistRemoved from wishlist 0
Add to compare
14″ Laptop Computer, Windows 11 Laptop for MS Office, 8GB RAM 512GB SSD, Intel Pentium Quad-Core Processor(Up to 2.64GHz), 1080P FHD IPS, Wi-Fi 5, BT5.0, HDMI, Students, Lightweight
Added to wishlistRemoved from wishlist 0
Add to compare
Original price was: €2,500.Current price is: €180.
93%

Bank of England warns growing risk AI bubble could burst

Soaring valuations of technology firms could drop sharply amid potentially “disappointing” progress around artificial intelligence (AI), the Bank of England has warned.

Big US tech companies like Nvidia, Google and Microsoft have all seen their share prices soar over the past year, driven by expectations that the adoption of AI technology will ramp up around the world.

But the central bank’s financial policy committee (FPC) warned that the risk of a “sharp correction” in the financial markets has increased.

The minutes of the FPC’s latest meeting read:

On a number of measures, equity market valuations appear stretched, particularly for technology companies focused on artificial intelligence.

This, when combined with increasing concentration within market indices, leaves equity markets particularly exposed should expectations around the impact of AI become less optimistic.

It said there was a risk that “disappointing” progress on AI capability or adoption, or increased competition, could drive valuations lower across the sector.

“Material bottlenecks to AI progress” including across power, data, or commodity supply chains could also harm valuations, particularly for firms that are expected to benefit from greater AI investment, the committee said.

Share

Updated at 

Key events

NHS could pay 25% more for medicines under plan to end row with drugmakers and Trump

Ministers are preparing to raise the amount the NHS pays pharmaceutical firms for medicines by up to 25% after weeks of intensive talks with the Donald Trump administration and drugmakers.

The government has drawn up fresh proposals to end a standoff with the industry over drug pricing, including changing the cost-effectiveness thresholds under which new medications are assessed for use on the NHS, according to industry sources.

The row has been cited as one of the reasons why big companies in the sector, including MSD (known as Merck in the US) and AstraZeneca, have cancelled or paused investments in the UK in recent weeks, while ramping up investments in the US.

The health department is in a standoff with the Treasury and No 10 on how to fund the deal, with Downing Street resisting pressure to commit new funds for medicines in next month’s budget.

The Liberal Democrats immediately attacked the move, first reported by Politico, asking how much it would cost and whether it would lead to cuts elsewhere in the NHS.

The science minister, Patrick Vallance, has publicly acknowledged that the UK’s spending on new medicines needs to rise, from 9% of overall NHS spend, which is below drug spending in the US and many other European countries.

The main element of the plan is thought to include raising the National Institute for Health and Care Excellence (Nice) cost-effectiveness threshold by 25%. Under current rules, NICE considers a medicine costing between £20,000 and £30,000 for every extra year of good-quality life it delivers to a patient to represent good value for money for the NHS.

Share


Added to wishlistRemoved from wishlist 0
Add to compare
2K Webcam for PC with Microphone & Light & Privacy Cover, Web Camera for Desktop Computer/Laptop/Monitor/Mac, USB Streaming Camera for Zoom/Skype/Teams/Video Calling/Studying and Conference
Added to wishlistRemoved from wishlist 0
Add to compare
Original price was: €60.Current price is: €40.
33%

We will be happy to hear your thoughts

Leave a reply

techbazar.tech
Logo
Compare items
  • Total (0)
Compare
0
Shopping cart